Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

52.95 -0.14 (-0.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,211,855
Open 53.09
Bid (Size) 52.33 (4)
Ask (Size) 53.50 (1)
Prev. Close 53.09
Today's Range 52.38 - 53.96
52wk Range 51.56 - 73.51
Shares Outstanding 183,352,255
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
1 Mid-Cap Stock to Research Further and 2 That Underwhelm
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade

Performance

YTD
-20.4%
-20.4%
1 Month
-0.4%
-0.4%
3 Month
-9.3%
-9.3%
6 Month
-10.0%
-10.0%
1 Year
-24.9%
-24.9%

More News

Read More
Is BioMarin Pharmaceutical Inc Gaining or Losing Market Support?
Via Benzinga
6 Analysts Assess BioMarin Pharmaceutical: What You Need To Know
Via Benzinga
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Presents a Compelling Value Investment Case
Via Chartmill
Peering Into BioMarin Pharmaceutical's Recent Short Interest
Via Benzinga
2 Profitable Stocks on Our Watchlist and 1 We Turn Down
Via StockStory
Reflecting On Therapeutics Stocks’ Q2 Earnings: BioMarin Pharmaceutical (NASDAQ:BMRN)
Via StockStory
Topics Artificial Intelligence
PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment
Via Benzinga
Why BioMarin Pharmaceutical (BMRN) Stock Is Down Today
Via StockStory
Topics Artificial Intelligence Economy
Forecasting The Future: 5 Analyst Projections For BioMarin Pharmaceutical
Via Benzinga
This Duolingo Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
2 Growth Stocks to Stash and 1 We Ignore
Via StockStory
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): A Value Investing Case Study in Undervaluation
Via Chartmill
2 Safe-and-Steady Stocks to Keep an Eye On and 1 Facing Challenges
Via StockStory
What's Driving the Market Sentiment Around BioMarin Pharmaceutical?
Via Benzinga
3 of Wall Street’s Favorite Stocks to Consider Right Now
Via StockStory
2 Reasons to Watch BMRN and 1 to Stay Cautious
Via StockStory
Topics Stocks
Predicting the Next Rule Breaker Buyout
Via The Motley Fool
Topics Artificial Intelligence
Elliott Management Bets Against S&P 500, Nasdaq 100, Nvidia Stock In Second Quarter
Via Benzinga
Topics Stocks
Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know
Via StockStory
Topics Earnings Economy
BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN): A Prime Value Investment with Strong Fundamentals and Growth Potential
Via Chartmill
BMRN Q2 Deep Dive: Pipeline Advances and Strategic Expansion Drive Upbeat Results
Via StockStory
Is BioMarin Pharmaceutical Gaining or Losing Market Support?
Via Benzinga
BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030
Via Benzinga

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 52.95
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 10/16/25 04:00 PM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 9.71B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.